Finally, FGFR3 which is overexpressed in t(4:14) translocation was demonstrated to confer resistance to dexamethasone in MM cells [54], and FGFR3 has been used as a drug target in t(4:14)-positive MM cells [25, 55]. This evidence concerns the gene FGFR3 and Miyoshi myopathy.